Peptide Therapeutics Market Landscape, Application, Development, Analysis And Forecasts To 2025
Global Peptide Therapeutics Market is predicted to reach USD 48.04 billion by 2025 owing to rise in demand for efficient & speedy treatment of cancer and other lifestyle-related disorders. Peptides are the naturally occurring biological molecules that are used in drugs to improve the patient’s medical condition.”
Global Peptide Therapeutics Market is predicted to reach USD 48.04 billion by 2025 owing to rise in demand for efficient & speedy treatment of cancer and other lifestyle-related disorders. Peptides are the naturally occurring biological molecules that are used in drugs to improve the patient’s medical condition.”
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Peptide</strong> <strong>Therapeutics</strong> <strong>Market</strong> <strong>Landscape</strong>, <strong>Application</strong>,<br />
<strong>Development</strong>, <strong>Analysis</strong> <strong>And</strong> <strong>Forecasts</strong> <strong>To</strong> <strong>2025</strong><br />
“Global <strong>Peptide</strong> <strong>Therapeutics</strong> <strong>Market</strong> is predicted to reach USD 48.04 billion<br />
by <strong>2025</strong> owing to rise in demand for efficient & speedy treatment of cancer<br />
and other lifestyle-related disorders. <strong>Peptide</strong>s are the naturally occurring<br />
biological molecules that are used in drugs to improve the patient’s medical<br />
condition.”<br />
Global <strong>Peptide</strong> <strong>Therapeutics</strong> <strong>Market</strong> is predicted to reach USD 48.04 billion by <strong>2025</strong> owing to rise in demand<br />
for efficient & speedy treatment of cancer and other lifestyle-related disorders. <strong>Peptide</strong>s are the naturally<br />
occurring biological molecules that are used in drugs to improve the patient’s medical condition. They are highly<br />
safe and effective due to which they are widely accepted by physicians and patients for treating several ailments.<br />
In the medical practice, they are ideal for diabetes, infectious diseases, several type of cancers, cardiovascular<br />
and other medical conditions. <strong>Peptide</strong>s are highly modifiable and versatile in comparison to other drugs, which<br />
make them highly profitable to sponsors. Due to their feature of versatility, they are used in multiple medical<br />
conditions that leads to higher penetration of peptide therapeutics industry. Apart from therapeutics effects,<br />
the market is also gaining attraction due to comparatively easy marketing approval and familiarity.<br />
Along with the growing prevalence of cardiovascular disorders and cancers, the increasing research &<br />
development activities and rich peptide therapeutics pipeline are predicted to support the growth of the market<br />
in near future. The patent expiration of various peptide drugs in future is expected to create ample opportunities<br />
for the market contributing to its growth at a significant rate. <strong>Peptide</strong> therapeutics have application in CNS<br />
(Central Nervous System) disorders and respiratory disorders due to features like safe, efficiency and versatility.<br />
Advanced research & development facilities and new peptide developments by pharma companies are driving<br />
the demand for reasonably priced peptide therapeutics.<br />
Request Sample Copy of this <strong>Market</strong> Research @<br />
https://www.millioninsights.com/industry-reports/peptide-therapeutics-market/request-sample
Nevertheless, the large scale production of peptide with increasing complexities of peptides is a major challenge<br />
for peptide therapeutics market. The development of multifunctional peptides and rise in number of<br />
collaboration for the progress of peptide conjugates are currently ruling the market.<br />
Latest advances in peptide synthesis technology is projected to be the key driver for the growth of peptide<br />
therapeutics industry. From among the different methods of peptide synthesis, enzymatic and chemical<br />
synthesis are important. This technology has integrated structure-activity relationships (SARs) and analog<br />
generation to increase bioavailability, increase safety & efficacy of drugs, impart protease resistance, reduce<br />
adverse effects, and develop formulations.<br />
The other driving factor of the market is the shift towards unexploited market. The market is witnessing several<br />
vendors focusing on developing economies due to presence of large population groups and clinical trial subjects.<br />
Factors like presence of lenient regulatory guidelines, skilled labor, limited market competition, and low<br />
manufacturing costs will encourage vendors to shift their manufacturing processes to the developing<br />
economies.<br />
<strong>Peptide</strong> therapeutics market is categorized on the basis of application, technology, route of administration,<br />
molecule type, API peptide type, and geography. On the basis of application, the market is divided into Cancer,<br />
Metabolic, CVD, Respiratory, GIT, Anti-infective, Dermatology, CNS, Renal, etc. In terms of route of<br />
administration, the market is segmented as Parenteral, Oral, etc.<br />
Browse Full Research Report @<br />
https://www.millioninsights.com/industry-reports/peptide-therapeutics-market<br />
On the basis of type, peptide therapeutics industry is divided into Innovative and Generic. On the basis of<br />
technology, the market is classified into Liquid Phase, Solid Phase, and Hybrid Phase. Type of Molecule is<br />
classified into Vasopressin, Somatostatin, Calcitonin, Immunopeptide, Natriuretic, and others. On the basis of<br />
API <strong>Peptide</strong> Type, the market is divided into In-house, and CMO (contract manufacturing organization).<br />
Geographically, peptide therapeutics market is segmented as North America, Latin America, Europe, Asia Pacific,<br />
and Middle East & Africa. North America and Latin America are predicted to hold larger share of the market<br />
owing to the rising incidences of cancer and other life-style related disorders.<br />
The key peptide therapeutics industry players comprise AstraZeneca plc, Amgen Inc., Eli Lilly and Company,<br />
Sanofi, CordenPharma International GmbH, Teva Pharmaceutical Industries Ltd., Novartis AG, Ipsen S.A., Lonza<br />
Group Ltd., Merck & Co. Inc., F. Hoffmann-La Roche AG, Bachem Holding AG, Poly<strong>Peptide</strong> Group and Novo<br />
Nordisk A/S.<br />
<strong>Market</strong> Segment:<br />
<strong>Peptide</strong> <strong>Therapeutics</strong>, <strong>Application</strong> Outlook (Revenue, USD Million; 2014 - <strong>2025</strong>)<br />
• Cancers
• Metabolic<br />
• Cardiovascular Disorder<br />
• Respiratory<br />
• GIT<br />
• Antiinfection<br />
• Pain<br />
• Dermatology<br />
• CNS<br />
• Renal<br />
• Others<br />
<strong>Peptide</strong> <strong>Therapeutics</strong>, Type Outlook (Revenue, USD Million; 2014 - <strong>2025</strong>)<br />
• Generic<br />
• Innovative<br />
<strong>Peptide</strong> <strong>Therapeutics</strong>, Type of Manufacturers Outlook (Revenue, USD Million; 2014 - <strong>2025</strong>)<br />
• In-house<br />
• Outsourced<br />
<strong>Peptide</strong> <strong>Therapeutics</strong>, Route of Administration Outlook (Revenue, USD Million; 2014 - <strong>2025</strong>)<br />
• Parenteral Route<br />
• Oral Route<br />
• Pulmonary<br />
• Mucosal<br />
• Others<br />
<strong>Peptide</strong> <strong>Therapeutics</strong>, Synthesis Technology Outlook (Revenue, USD Million; 2014 - <strong>2025</strong>)<br />
• Solid Phase <strong>Peptide</strong> Synthesis (SPPS)<br />
• Liquid Phase <strong>Peptide</strong> Synthesis (LPPS)<br />
• Hybrid Technology<br />
<strong>Peptide</strong> <strong>Therapeutics</strong>, Regional Outlook (Revenue, USD Million; 2014 - <strong>2025</strong>)<br />
• North America<br />
• Europe<br />
• Asia Pacific<br />
• Latin America<br />
• MEA<br />
See More Reports of this Category by Million Insights @<br />
https://www.millioninsights.com/industry/pharmaceuticals
Get in touch<br />
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our<br />
representatives strive to understand diverse client requirements and cater to the same with the<br />
most innovative and functional solutions.<br />
Contact Person:<br />
Ryan Manuel<br />
Research Support Specialist, USA<br />
Email: ryan@millioninsights.com<br />
Global Headquarters<br />
Million Insights<br />
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States<br />
Phone: 1-408-610-2300<br />
Email: sales@millioninsights.com<br />
Asia Pacific<br />
Million Insights<br />
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016<br />
India<br />
Phone: 91-20-65300184
Change language